Display Settings:

Format

Send to:

Choose Destination
    Neurology. 2005 Feb 8;64(3):509-13.

    Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.

    Source

    Department of Psychiatry and Behavioral Sciences, School of Public Health, University of Washington, Seattle, USA. dwt1@u.washington.edu

    Abstract

    OBJECTIVE:

    To explore the association between APOE*4 and pathologically confirmed cases of the Lewy body (LB) variant of Alzheimer disease (AD).

    METHODS:

    With use of alpha-synuclein (AS) immunohistochemistry, LBs were detected in 74 of 131 (56.5%) of the AD + LB cases; the remaining 57 cases (43.5%) did not have LBs.

    RESULTS:

    There were no differences in gender or age between Caucasian subjects with AD + LB or AD alone or control subjects. The APOE*4 allele frequency was highest in the AD + LB group (47.3%; 95% CI = 37.8 to 57.0%), intermediate in the AD-alone group (35.1%; 95% CI = 25.3 to 46.3%), and lowest in the control group (14.2%; 95% CI = 10.5 to 18.9%). With use of logistic regression analysis, the odds of having AD + LB vs AD alone were 2.1-fold (95% CI = 1.0 to 4.5, p = 0.055) greater in persons with an APOE*4 allele than in those without an APOE*4 allele.

    CONCLUSION:

    The APOE*4 allele is associated with the presence of concomitant Lewy bodies in Alzheimer disease.

    PMID:
    15699383
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1487185
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk